Abetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease

Author： Cardiel Mario H  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.1, 2005-01, pp. : 77-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Filgrastim: Renal disease flares in patients with systemic lupus erythematosus: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1124, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus

By Mosca Marta   Baldini Chiara   Bombardieri Stefano  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 873-879

Informa Healthcare

Access to resources Recommend Favorite

Effect of Renal Disease on the Standardized Mortality Ratio and Life Expectancy of Patients With Systemic Lupus Erythematosus

By  

Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. : 2154-2160

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ethinylestradiol/levonorgestrel: Major flares of systemic lupus erythematosus: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1181, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Gene Therapy in Systemic Lupus Erythematosus

By  

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 677-684

Bentham Science Publishers

Access to resources Recommend Favorite